
Castle Biosciences Inc
NASDAQ:CSTL

Intrinsic Value
The intrinsic value of one
CSTL
stock under the Base Case scenario is
25.34
USD.
Compared to the current market price of 16.08 USD,
Castle Biosciences Inc
is
Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Castle Biosciences Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Castle Biosciences Inc
Balance Sheet Decomposition
Castle Biosciences Inc
Current Assets | 349.4m |
Cash & Short-Term Investments | 275.2m |
Receivables | 56.4m |
Other Current Assets | 17.9m |
Non-Current Assets | 152.3m |
Long-Term Investments | 5.6m |
PP&E | 66.6m |
Intangibles | 77.9m |
Other Non-Current Assets | 2.3m |
Free Cash Flow Analysis
Castle Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Castle Biosciences Inc
Revenue
|
347.1m
USD
|
Cost of Revenue
|
-62.7m
USD
|
Gross Profit
|
284.4m
USD
|
Operating Expenses
|
-298.2m
USD
|
Operating Income
|
-13.8m
USD
|
Other Expenses
|
8.7m
USD
|
Net Income
|
-5.1m
USD
|
CSTL Profitability Score
Profitability Due Diligence
Castle Biosciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
Castle Biosciences Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
CSTL Solvency Score
Solvency Due Diligence
Castle Biosciences Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Score
Castle Biosciences Inc's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CSTL
is 36.61 USD
with a low forecast of 30.3 USD and a high forecast of 43.05 USD.
Dividends
Current shareholder yield for CSTL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CSTL
stock under the Base Case scenario is
25.34
USD.
Compared to the current market price of 16.08 USD,
Castle Biosciences Inc
is
Undervalued by 37%.